SCHEMBL24718659

SCHEMBL24718659

O=C(NC1CC(=O)N(Cc2ccccc2C(F)(F)F)C1)c1cc(F)ccc1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ TP53 P04637 1/20 0.46
▸ RIPK1 Q13546 1/20 0.42
▸ CHRM5 P08912 1/20 0.41
▸ P2RX7 Q99572 1/20 0.41
▸ SIRT2 Q8IXJ6 1/20 0.40
▸ SIRT1 Q96EB6 1/20 0.40
▸ LMNA P02545 1/20 0.39
▸ EPHX2 P34913 3/20 0.39
▸ P2RX1 P51575 1/20 0.38
▸ TMPRSS4 Q9NRS4 1/20 0.38
▸ TACR1 P25103 2/20 0.38
▸ PPARG P37231 1/20 0.38
▸ PPIA P62937 1/20 0.37
▸ USP30 Q70CQ3 2/20 0.37
▸ HDAC11 Q96DB2 1/20 0.37
▸ SIGMAR1 Q99720 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24718241 0.91 TP53 (0.46) MEN1ALDH1A1GAAKMT2ATP53
SCHEMBL24718416 0.91 TP53 (0.46) MEN1ALDH1A1GAAKMT2ATP53
SCHEMBL24718382 0.91 TP53 (0.46) MEN1ALDH1A1GAAKMT2ATP53
SCHEMBL24718415 0.90 TP53 (0.49) MEN1ALDH1A1GAAKMT2ATP53
SCHEMBL24718273 0.90 TP53 (0.47) MEN1ALDH1A1GAAKMT2ATP53
SCHEMBL24718840 0.90 TP53 (0.45) MEN1ALDH1A1GAAKMT2ATP53
SCHEMBL24718419 0.90 TP53 (0.45) MEN1ALDH1A1GAAKMT2ATP53
SCHEMBL24718645 0.90 TP53 (0.45) MEN1ALDH1A1GAAKMT2ATP53
SCHEMBL24718637 0.89 TP53 (0.49) MEN1ALDH1A1GAAKMT2ATP53
SCHEMBL24718834 0.88 TP53 (0.46) MEN1ALDH1A1GAAKMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220363633-A1 SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING UNITED STATES GOVERNMENT 2022-11-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220363633-A1 SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING EED, EZH2, ELP1 MEN1 3534/4885ALDH1A1 1312/4885GAA 4271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback